Page 5 - John Mafi News Today

Highlights from NPR, the Wall Street Journal, the New York Times and others.

A UCLA-led cost analysis of the controversial new Alzheimer’s disease drug aducanumab shows that ancillary care services, such as additional MRIs and

Americans' use of common outpatient health services dipped sharply at the outset of the COVID-19 pandemic, then rebounded to near-normal levels by the end of 2020, only to decline again during the second surge in January–February 2021, according to a new UCLA-led study.

Research brief: Additional services to monitor the drug’s potential side effects account for nearly 20% of its total costs, a UCLA-led study shows.

While the situation improved, economically disadvantaged patients were far less likely to return to using services at normal, pre-pandemic levels.

Americans’ use of common outpatient health services dipped sharply at the outset of the COVID-19 pandemic, then rebounded to near-normal levels by the

A new cost analysis taking into account spending on ancillary health services suggests that prior cost analyses underestimated the anticipated costs of aducanumab.

These 4 supplements, vitamins, and minerals can help your immune system fight off colds and the flu.

A team of scientists have said that allowing people to write their own medical records can actually help the patients feel more involved in the treatment.

UCLA RESEARCH BRIEF Shopify Partners/Burst Under the Affordable Care Act, the secretary of health and human services is authorized to prohibit payment for services given a “D” rating by the U.S. Preventive Services Task Force, the researchers say. Enrique Rivero | FINDINGS A UCLA-led study shows that physicians frequently order preventive medical services for adult Medicare beneficiaries that are considered unnecessary and of “low value” by the U.S. Preventive Services Task Fo...